The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective

The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective

Over the past decade, the development of high-efficacy disease-modifying therapies (DMTs) has been responsible for more effective management of relapsing-remitting multiple sclerosis (RRMS). However, the gaps in optimal care for this complex disease remain. Alemtuzumab (Lemtrada®) is a highly effica...

Full description

Bibliographic Details
Main Authors: Raed Alroughani, Bart Van Wijmeersch, Jabber Al Khaboori, Isa Ahmed Alsharoqi, Samar F. Ahmed, Ali Hassan, Jihad Inshasi, Derk W. Krieger, Mustafa Shakra, Ahmed Osman Shatila, Miklos Szolics, Mohamed Khallaf, Aly Ezzat
Format: Article
Language:English
Published: SAGE Publishing 2020-09-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/1756286420954119

Internet

https://doi.org/10.1177/1756286420954119

Similar Items